$9.69
1.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 1
Data gathered: December 1
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 10 0% |
|
| App downloads | 0% | N/A |
| Sentiment | 89 0% |
|
| Webpage traffic | 74,000 13.1% |
|
| Employee Rating | 69 0% |
|
| Google Adspend | $643 39.5% | N/A |
| Google Trends | 22 0% |
|
| Linkedin Employees | 261 N/A |
|
| Patents | 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 10 11.1% |
|
| Facebook followers | 7,265 -0% |
|
| Stocktwits Mentions | 2 0% |
|
| Stocktwits Subscribers | 3,781 -0.1% |
|
| Twitter Followers | 627 0% |
|
| Instagram Followers | 46,033 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | -100% |
|
| Business outlook | 56 0% |
|
In the news
Evolus management to meet with NeedhamNovember 13 - Thefly.com |
|
 |
Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call TranscriptNovember 12 - Yahoo |
 |
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 10 - Yahoo |
Evolus Exceeds Expectations: Sustained Growth and Raised Guidance Lead to Buy RatingNovember 9 - TipRanks |
|
About Evolus
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States.
| Price | $9.69 |
| Target Price | Sign up |
| Market Cap | $544M |
| Dividend Yield | 0 |
| Industry | Drug Manufacturers |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$157.8 2% | 52 |
 |
Eli Lilly and CompanyLLY |
$584.35 1.1% | 60 |
 |
PfizerPFE |
$28.89 4.6% | 55 |
 |
AstrazenecaAZN |
$64.78 0.7% | 68 |
 |
AbbVieABBV |
$143.11 0.7% | 58 |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 46M | 60M | -14M | -17M | -12M |
| Q2 '23 | 46M | 57M | -11M | -18M | -14M |
| Q1 '23 | 39M | 50M | -12M | -15M | -11M |
| Q4 '22 | 41M | 51M | -10M | -13M | -9.6M |
| Q3 '22 | 32M | 49M | -18M | -20M | -17M |
Insider Transactions
| Medytox Inc. filed to sell 3,381,326 shares at $7.5. October 18 '23 |
| Beaver Sandra filed to sell 113,368 shares at $9.7. September 8 '23 |
| MOATAZEDI DAVID filed to sell 686,592 shares at $10.3. August 16 '23 |
| Beaver Sandra filed to sell 116,546 shares at $10.3. August 16 '23 |
| Avelar Rui filed to sell 353,386 shares at $10.3. August 16 '23 |
Read more about Evolus and their earnings, price prediction, job posts, app downloads, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.